跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Epiberberine
首页
药物
Epiberberine
Epiberberine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Nasal irrigation solutions and methods of using same
US 7771757 B2
申请人: HIMALAYAN INTERNAT INST OF YOG
优先权: 2003
US
3 件公开
Coptis chinensis total alkaloid extracting technique
CN 101269132 B
申请人: UNIV SOUTHWEST
优先权: 2008
CN
Method for separating and purifying monomer compounds from Chinese medicinal herb rhizoma coptidis
CN 102285982 B
申请人: UNIV LIAOCHENG
优先权: 2011
CN
Synthetic method of epiberberine
CN 103387574 A
申请人: BEIJING YILING PHARMACEUTICAL CO LTD
优先权: 2012
CN
Efficient extraction method of total coptis alkaloids
CN 104644793 A
申请人: UNIV SOUTHWEST
优先权: 2015
CN
Preparation method of rhizoma coptidis extract under normal temperature
CN 106344675 A
申请人: JIANGSU CHUNSHENTANG PHARMACEUTICAL CO LTD
优先权: 2016
CN
Traditional Chinese medicine composition with effects of purging fire and detoxifying and preparation method thereof
CN 106727646 A
申请人: HARBIN ZHENBAO PHARMACEUTICAL CO LTD
优先权: 2016
CN
Application of rhizaoma coptidis or processed product thereof
CN 107213215 A
申请人: UNIV SOUTHWEST JIAOTONG
优先权: 2017
CN
Medical applications of epiberberine
CN 107349201 A
申请人: SHANGHAI HUAJIN BIOTECHNOLOGY CO LTD
优先权: 2017
CN
Beta2-adrenergic receptor antagonist and application
CN 109893651 A
申请人: DALIAN INST CHEM & PHYSICS CAS
优先权: 2017
CN
第 1 / 3 页
上一页
下一页
药物
反馈